<
The State Medical Insurance Administration joined the State Council to deepen the leadership of the medical reform
Release time: 2018-07-10 & nbsp & nbsp & nbsp Source: Anonymous

Recently,China Government Network issued a notice from the State Council's General Office of the State Council's Deepening the State Council's Deepening the Reform of the Medical and Health System (Guo Office [2018] No. 56),Deepening the leadership group of the reform of the medical and health system (referred to as "deep reorganization") was adjusted,The team leader is the Vice Premier of the State Council Sun Chunlan,The deputy team leader He Lifeng is the director of the Development Reform Commission, respectively、Director of the Health and Health Committee Ma Xiaowei、Minister of Finance Liu Kun、Zhang Jinan, Minister of Human Resources and My stake betting appSocial Security、Deputy Secretary -General of the State Council Ding Xiangyang、Hu Jinglin, director of the Medical Insurance Bureau。

According to the notification introduction,The Secretariat of the Leading Group is located in the Health Committee,Daily work of undertaking the leadership group,Responsible for studying and proposing a major policy for deepening the reform of the medical and health system、Policy、Suggestions for measures,Supervisory and implementation of the matters of the leadership group meeting,Other matters assigned by the leadership group; Ma Xiaowei is also the director of the secretariat,Lianwei Liang、Wang He Sheng、Lianwei Liang、Yu Weiping、Qiu Xiaoping、Li Tao、Xu Jinghe as the deputy director of the Secretariat。The specific work of the Secretariat shall be borne by the Reform Department of the System Reform of the Health Committee。

This adjustment,Compared with the members of the previous depth reorganization organization,Deputy Leader Unit Except for the Health and Health Commission (Health and Family Planning Commission)、Development and Reform Commission、Ministry of Finance、Ministry of Human Resources and Social Affairs、State Council,The newly listed Medical Insurance Bureau officially joined the deep reorganization this year,Directly reflects the important wind direction of the reform of the medical and health system in the new period。

Supplement drug supply shortcomings

March 2018,The reform plan of stake online sports bettingthe State Council is officially released,Clarify the establishment of the National Medical Security Bureau。Due to the functional positioning of the National Medical Insurance Bureau、Medical Insurance Directory and other market access,You can adopt the method of closer bidding for the bid price of the drug and the medical insurance payment standard to determine the drug supply,Therefore, the right to control costs from the source,It is bound to adjust the drug supply through the reform payment method,Especially clinical urgent need of medicines will get the focus of focus。

Recently,Health and Health Committee、Medical Insurance Bureau、Drug Administration and other departments have released policies in succession,Increase the coverage of tumor drug medical insurance、The reduction in price through negotiation has become a clear direction for deepening medical security reform,Self -funded drugs in the tax reduction catalog and some recently approved innovative drugs may become the object of negotiation。At the same time,Encourage domestic high -quality generic drug clinical use,Realizing the original imported imported drug replacement,will be the general trend。

On the other hand,Improve the efficiency of medical insurance funds,Optimized Payment,In the future clinical medication upgrade will completely change the traditional clinical medication pattern,For medicines with huge previous dosage、Auxiliary medication will be directly controlled under the ceiling of the medical insurance control My stake betting appfee。It can be said,Administration of the Medical Insurance Bureau joined the reorganization,It will directly affect the operating strategy of pharmaceutical companies from multiple angles,It is even about product fate。

DRGS Precision Fees

For a long time,Prescription drug sales of public medical institutions account for more than 70 % of the total domestic drug retail sales,The hospital is in the monopoly position of the buyer's market,As a result, a large number of pharmaceutical industrial and commercial enterprises lack sufficient bargaining ability in the market,The resources of the pharmaceutical industry chain are difficult to get optimized allocation。

Traditional medical insurance pays the hospital's payment method to pay according to the project,Clinicians have excessive diagnosis and treatment in order to obtain gray income,and the same way as the medical institution "supplement medicine with medicine" is consistent。Hospital terminal lacks reduction of medical treatment、The inherent driving force of the cost of the drug,The restraint of medical insurance on medical institutions is limited,Although "medicine separate" explores for many years,But the advance speed is still slow。

Key nodes of the reform of the medical payment mechanism,Deep reorganization organizational structure adjustment,It will lay a more operable policy reform and regulatory basis for the realization of "medical separation",In the past, relying on drug high pricing、Channel space big,"Gao Raner and stake sports betting appHigh Play" to drive the sales of drug marketing methods will be changed,The operating behavior of drug production enterprises will have a revolutionary impact。With a new incentive and restraint mechanism,Medical terminals will also generate active reduction in drug purchasing prices、Endogenesis of optimizing medical service behavior。